Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Cash from Operations (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Cash from Operations for 2 consecutive years, with 2368023.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 35.93% to 2368023.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5413736.0 through Dec 2025, down 38.42% year-over-year, with the annual reading at 5413736.0 for FY2025, 38.42% down from the prior year.
  • Cash from Operations for Q4 2025 was 2368023.0 at Jupiter Neurosciences, down from 1154450.0 in the prior quarter.
  • The five-year high for Cash from Operations was 42598.0 in Q3 2024, with the low at 3695779.0 in Q4 2024.